Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Nonviral technologies can pave the way for CAR-NK cell therapy

4 Jul 2023

Abstract excerpt

Natural killer cells are a promising platform for cancer immunotherapy. Natural killer cells have high intrinsic killing capability, and the insertion of a chimeric antigen receptor can further enhance their antitumor potential. In first-in-human trials, chimeric antigen receptor-natural killer cells demonstrated strong clinical activity without therapy-induced side effects. The applicability of natural killer...

Topics

Join the communities discussing this publication.

CAR-T cell therapy research
Immune Cell Function and Interaction
RNA Interference and Gene Delivery

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 37403203
DOI: 10.1093/jleuko/qiad074

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Nonviral technologies can pave the way for CAR-NK cell therapyPMID 37403203Read ↗

Nonviral genome engineering of natural killer cellsSemantic proximity Read ↗

Genetic Manipulation Approaches to Enhance the Clinical Application of NK Cell-Based ImmunotherapySemantic proximity Read ↗

Non-viral approaches in CAR-NK cell engineering: connecting natural killer cell biology and gene deliverySemantic proximity Read ↗

Gene-edited and CAR-NK cells: Opportunities and challenges with engineering of NK cells for immunotherapySemantic proximity Read ↗

CRISPR, CAR-T, and NK: Current applications and future perspectivesSemantic proximity Read ↗

Optimization and validation of CAR transduction into human primary NK cells using CRISPR and AAVSemantic proximity Read ↗

Choosing the Right Tool for Genetic Engineering: Clinical Lessons from Chimeric Antigen Receptor-T CellsSemantic proximity Read ↗

A robust platform for expansion and genome editing of primary human natural killer cellsSemantic proximity Read ↗

Chimeric antigen receptor-natural killer cell therapy: a new force in intrinsic immunotherapy for cancer treatmentSemantic proximity Read ↗

Engineering NK Cells for CAR Therapy—Recent Advances in Gene Transfer MethodologySemantic proximity Read ↗

Application and prospects of genetic engineering in CAR-NK cell therapySemantic proximity Read ↗

Site-specific genome engineering of primary human natural killer cells for programmable anti-tumor functionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.